In preclinical animal trials, third-party testing results showed that AIM Vaccine's mRNA RSV vaccine achieved significantly ...

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...

Bird flu isn’t part of the “quad-demic” of viruses circulating through the country this winter—COVID, seasonal flu, respiratory syncytial virus (RSV), and norovirus ... the development of a bird flu ...

designed to protect against RSV and COVID-19. Beyond vaccines, pharma is looking to develop mRNA vaccines to treat diseases requiring protein expression, such as cancer. Cancer has proved to be a ...

The international consulting firm Clarivate makes its bet among the novelties ready for the medicine cabinet this year: three ...

As Moderna maps out a more cautious future amid lower-than-expected sales of its current products, the company is bolstering ...

"Medidata is at the forefront of a critical shift in the life sciences sector," said Anthony Costello, CEO, Medidata. "By harnessing AI-powered solutions and partnering with visionaries, we aren't ...

The VDH and Scott are advocating for people to get their vaccinations before winter. Scott said he has received his COVID ...

BRITS are being urged to stay at home and mask up when venturing outside after a “worrying” surge in norovirus cases. While ...

The first patients have been dosed in a phase 3 trial of an mRNA-based seasonal influenza ... while a triple shot that also adds in respiratory syncytial virus (RSV) should also reach the clinic ...

The S&P500 closed in the red on Friday, after the week saw a massive sell-off of AI-related stocks sparked by worries around ...

Major stock indexes closed lower on Friday, after the week saw a flurry of events, including DeepSeek scare and earnings ...